NTRK2 and osteosarcoma: Furthermore, activation of the BDNF–TrkB axis has been correlated with enhanced proliferation, resistance to apoptosis, and invasive behaviour in multiple malignancies, and similar molecular programmes have been described in experimental osteosarcoma systems (17, 18).